Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death.
about
Proteomic analysis of the secretome of Leishmania donovaniApoptosis-like death in trypanosomatids: search for putative pathways and genes involvedHost Cell Phenotypic Variability Induced by Trypanosomatid-Parasite-Released Immunomodulatory Factors: Physiopathological ImplicationsExperimental study of the function of the excreted/secreted Leishmania LmSIR2 protein by heterologous expression in eukaryotic cell lineThe Leishmania nicotinamidase is essential for NAD+ production and parasite proliferationAntimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites.Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases.Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.Sirtuins of parasitic protozoa: in search of function(s).The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity.Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity?In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidatesImmune response regulation by leishmania secreted and nonsecreted antigens.Molecular characterization and protective efficacy of silent information regulator 2A from Eimeria tenella.Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death.HDAC inhibitors in parasitic diseases.Secreted virulence factors and immune evasion in visceral leishmaniasis.Chromatin modifications in trypanosomes due to stress.Cryptolepine-Induced Cell Death of Leishmania donovani Promastigotes Is Augmented by Inhibition of Autophagy.Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani.Structural insights of SIR2rp3 proteins as promising biotargets to fight against Chagas disease and leishmaniasis.In vitro antileishmanial activity of nicotinamide.An experimental approach for the identification of conserved secreted proteins in trypanosomatids.Sir2-Related Protein 1 from Leishmania amazonensis is a glycosylated NAD+-dependent deacetylase.In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors.The crystal structure of the Leishmania infantum Silent Information Regulator 2 related protein 1: Implications to protein function and drug design.KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis.Histone deacetylases as targets for antitrypanosomal drugsSearching Genes Encoding Leishmania Antigens for Diagnosis and ProtectionLeishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies
P2860
Q21184106-4C6F40A1-1870-444A-A9EA-58869B068A27Q24791284-6CCAD365-59A7-4C3A-A840-9CDE223FA516Q24796644-1909FB71-D793-41C2-86CD-8393D2BE770BQ24800656-F28826A7-D36F-463B-A145-7B7ED4BD4FD2Q27671551-D7277ACA-0B4C-402E-A7A7-AAA162B28049Q33637372-328C3BC7-1256-44BE-B290-80104610A28DQ33883773-A913122B-FE98-48B6-AB3C-367808812BD0Q34795203-165375C2-2C57-46D3-AA86-AE4B06BAAB53Q35154482-7C6E2E72-A580-42C1-A615-2F0F3EEDAB75Q36357683-25502812-9D02-4101-B0C9-35A6CD173B1DQ36368943-466C7266-74D5-49B9-A5BE-7F7D03480C10Q36536935-8344456E-7E80-490C-9B2B-CC7C7806395DQ36660891-A861E22F-1851-4959-8F3A-5618554582BFQ36915063-58141512-726F-49E4-BDED-B4C584B1BC29Q37440560-F378542F-AB2C-490A-B8E3-07D10CAF02C5Q37810344-793BA597-EFE4-40E9-B96E-9ADE6341ACA3Q37962336-829B1B8A-039A-40B0-85EE-9C44BECFE9E2Q37996396-F5E9B342-BFA6-4D96-BA0F-E70C875CBE32Q38075578-D363B084-137D-46DC-9AE0-5A3492D1290DQ38738791-7E9CC86F-DE2C-4C9F-B1B0-ADA3DA639A7BQ39371673-5087B86B-9D41-4CB6-A5DA-247923805745Q39396789-951121C9-F4A5-457F-98E9-DFF19AF5E998Q41009075-799B2F7F-E678-497A-A6AE-63D8FCE3B63BQ42922068-DED2B1AE-EA71-4FCE-A77B-180CD116965BQ44341506-28123E00-CE91-465D-A065-3553C3F65B8BQ50893356-406F7DB5-2DFF-4DF0-BB0B-E1CB0A6E132BQ52354384-B9946CB9-BBFE-483A-868A-5317BCC39BFFQ52763318-44E372B4-D834-49C1-A880-6EA28F93E927Q57138418-34163C1C-24DE-4F85-B15F-15B64EF2AA40Q58647150-2890EA3C-02EC-413D-9386-07BDA7DF6151Q58854022-BFC19C17-F8F0-469D-9559-A70DB752047F
P2860
Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@ast
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@en
type
label
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@ast
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@en
prefLabel
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@ast
Cytoplasmic SIR2 homologue ove ...... venting programmed cell death.
@en
P2093
P1433
P1476
Cytoplasmic SIR2 homologue ove ...... eventing programmed cell death
@en
P2093
Ali Ouaissi
Jean-Loup Lemesre
Niloufar Madjidian-Sereno
P304
P356
10.1016/S0378-1119(02)00842-9
P407
P577
2002-08-01T00:00:00Z